New drug interaction study for opioid treatments launches
NCT ID NCT07314346
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-stage study looks at how a new antiviral drug combination (BEM/RZR) affects the levels of two common opioid addiction treatments—buprenorphine/naloxone and methadone—in healthy adults. Researchers will give participants their usual opioid therapy plus the antiviral drug and measure drug concentrations in the blood. The goal is to see if the antiviral changes how these opioids work in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Bemnifosbuvir/Ruzasvir (BEM/RZR) combined with buprenorphine/naloxone or methadone
What this could lead to
If successful, this study could help doctors understand how to safely combine a new antiviral drug with common opioid addiction treatments.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only checks drug levels, not whether the combination is safe or effective for treating disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atea Study Site
RECRUITINGHollywood, Florida, 33019, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Atea Study Site
RECRUITINGOverland Park, Kansas, 66212, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Atea Study Site
RECRUITINGMarlton, New Jersey, 08053, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••